75
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Striving for more good days: patient perspectives on botulinum toxin for the treatment of cervical dystonia

, &
Pages 1601-1608 | Published online: 22 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Andrew Morgan, Fiona J. R. Eccles & Pete Greasley. (2021) Experiences of living with dystonia. Disability and Rehabilitation 43:7, pages 944-952.
Read now
Bernd Leplow, Anna Eggebrecht & Johannes Pohl. (2017) Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia. Patient Preference and Adherence 11, pages 1555-1563.
Read now

Articles from other publishers (14)

Djamel Bensmail, Pierre Karam, Anne Forestier, Jean-Yves Loze & Jonathan Lévy. (2023) Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study. Toxins 15:4, pages 280.
Crossref
Christopher D. Stephen, Marisela Dy-Hollins, Claudio Melo De Gusmao, Xena Al Qahtani & Nutan Sharma. (2023) Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing. Seminars in Neurology 43:01, pages 017-034.
Crossref
Melani J. Boyce, Alana B. McCambridge, Lynley V. Bradnam, Colleen G. Canning & Arianne P. Verhagen. (2022) The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review. Neurological Sciences 43:8, pages 4663-4670.
Crossref
Kevin Chao, Amir Moradi & Saami Khalifian. (2022) DaxibotulinumtoxinA for injection: A review of the current data. Dermatological Reviews 3:4, pages 221-230.
Crossref
Serena Caverzasio, Ninfa Amato, Giacomo Chiaro, Claudio Staedler, Alain Kaelin-Lang & Salvatore Galati. (2022) Impairment of sleep homeostasis in cervical dystonia patients. Scientific Reports 12:1.
Crossref
Aurora M. James-Palmer & Jean-Francois Daneault. (2022) Tele-Yoga for the Management of Cervical Dystonia: A Safety and Feasibility Trial. Dystonia 1.
Crossref
Nowell Solish, Jean Carruthers, Joely Kaufman, Roman G. Rubio, Todd M. Gross & Conor J. Gallagher. (2021) Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs 81:18, pages 2091-2101.
Crossref
Chi Wang Ip, Axel Schramm, Pascal Maisonobe, Emma Zaragatski & Thomas Sycha. (2021) Behandlungszufriedenheit bei Patienten mit zervikaler DystonieTreatment satisfaction in patients with cervical dystonia. Der Nervenarzt 92:12, pages 1268-1275.
Crossref
Petr Kaňovský, Elie P. Elovic, Angelika Hanschmann, Irena Pulte, Michael Althaus, Reinhard Hiersemenzel & Christina Marciniak. (2021) Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis. Frontiers in Neurology 11.
Crossref
Pétala Tuani Candido de Oliveira Salvador, Kisna Yasmin Andrade Alves, Cláudia Cristiane Filgueira Martins Rodrigues & Lannuzya Veríssimo e Oliveira. (2020) Online data collection strategies used in qualitative research of the health field: a scoping review. Revista Gaúcha de Enfermagem 41.
Crossref
Qianzhi Jiang & Nancy L. Cohen. (2020) Use of Online Focus Groups for Nutrition and Health Studies. Topics in Clinical Nutrition 35:1, pages 9-18.
Crossref
Anna Castagna, Antonio Caronni, Alessandro Crippa, Luciana Sciumè, Giulia Giacobbi, Chiara Corrini, Angelo Montesano & Marina Ramella. (2019) Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia—an observational study. Neurological Sciences 41:1, pages 131-138.
Crossref
Jörg Wissel. (2018) Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity – Insights from recent studies. Toxicon 147, pages 100-106.
Crossref
Joseph Jankovic, Daniel Truong, Atul T. Patel, Allison Brashear, Marian Evatt, Roman G. Rubio, Chad K. Oh, Daniel Snyder, Gill Shears & Cynthia Comella. (2018) Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Movement Disorders Clinical Practice 5:3, pages 273-282.
Crossref